Effect of repeated ivermectin treatments on ocular onchocerciasis: Evaluation after six to eight dosings

Ophthalmic Epidemiology

Volumn 6, Issue 4, 1999, Pages 229-246

  Chippaux, J P ^a,f   Boussinesq, M ^a   Fobi, Grace ^b   Lafleur, C ^e   Auduge A ^d   Banos, M T ^d   Ngosso, A ^c   Prod'hon, J ^a  

^a CENTRE PASTEUR DU CAMEROUN   (Cameroon)

^b YAOUNDÉ CENTRAL HOSPITAL   (Cameroon)

^c Reference Hospital   (Cameroon)

^d French Ministry of Research   (France)

^e Ophtalmos Sans Frontieres (OSF)   (France)

^f Centre de Recherche Medicale et Sanitaire Niamey   (Niger)

Author keywords

Cameroon; Ivermectin; Keratitis; Ocular lesions; Onchocerciasis; Visual acuity

Indexed keywords

IVERMECTIN;

ADOLESCENT; ADULT; ARTICLE; CAMEROON; EYE FUNDUS; EYE INJURY; FEMALE; HUMAN; KERATITIS; MAJOR CLINICAL STUDY; MICROFILARIASIS; ONCHOCERCIASIS; OPHTHALMOLOGY; PRIORITY JOURNAL; PUNCTATE KERATITIS; VISUAL ACUITY;

EID: 0032755008     PISSN: 09286586     EISSN: None     Source Type: Journal    
DOI: 10.1076/opep.6.4.229.4185     Document Type: Article

References (34)

1. World Health Organization Expert Committee on Onchocerciasis Control. Technical Report Series 852. Geneva: WHO, 1995.
2. Taylor HR, Murphy RP, Newland HS, White AT, D'Anna SA, Keyvan-Larijani E, Aziz MA, Cupp EW, Greene BM. Treatment of onchocerciasis. The ocular effects of ivermectin and diethylcarbamazine. Arch Ophthalmol 1986; 104:863-70.
3. Dadzie KY, Bird AC, Awadzi K, Schulz-Key H, Gilles HM, Aziz MA. Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis. Br J Ophthalmol 1987; 71:78-85.
4. White AT, Newland HS, Taylor HR, Ertmann KD, Keyvan-Larijani E, Nara A, Aziz MA, D'Anna SA, Williams PN, Greene BM. Controlled trial and dose-finding study of ivermectin for treatment of onchocerciasis. J Infect Dis 1987; 156:463-70.
5. Vingtain P, Pichard E, Ginoux J, Coulibaly SM, Bissan Y, Ranque P, Thillaye B. Ivermectine et onchocercose humaine. A propos d'une étude portant sur 234 onchocerquiens en République du Mali. Bull Soc Path Exot 1988; 81:260-70.
6. Larivière M, Beauvais B, Aziz M, Garin YJF, Abeloos J, Derouin F, Bamba M, Bosseboeuf C, Ferly-Therizol M, Sarfati C, Basset D, Basset A, Touré Y, Song D, Gaxotte P. Etude en Côte-d'Ivoire (1985-1987) de l'efficacité et de la tolérance de l'ivermectine (Mectizanγ) dans l'onchocercose humaine. I. Etude comparative en double insu de 220 sujets onchocerquiens traités par dose unique orale de 100, 150 ou 200 mcg/kg. Bull Soc Path Exot 1989; 82:35-47.
7. Taylor HR, Semba RD, Newland HS, Keyvan-Larijani E, White A, Dukuly Z, Greene BM. Ivermectin treatment of patients with severe ocular onchocerciasis. Am J Trop Med Hyg 1989; 40:494-500.
8. Dadzie KY, Remme J, Alley ES, De Sole G. Changes in ocular onchocerciasis four and twelve months after community-based treatment with ivermectin in a holoendemic onchocerciasis focus. Trans R Soc Trop Med Hyg 1990; 84:103-8.
9. Dadzie KY, Remme J, De Sole G. Changes in ocular onchocerciasis after two rounds of community-based ivermectin treatment in a holoendemic onchocerciasis focus. Trans R Soc Trop Med Hyg 1991; 85:267-71.
10. Moyou Somo R, Ngosso A, Dinga JS, Enyong PA, Fobi G. A community-based trial of ivermectin for onchocerciasis control in the forest of southwestern Cameroon: Clinical and parasitologic findings after three treatments. Am J Trop Med Hyg 1993; 48:9-13.
11. Awadzi K, Dadzie KY, Kläger S, Gilles HM. The chemotherapy of onchocerciasis. XIII. Studies with ivermectin in onchocerciasis patients in northern Ghana, a region with long lasting vector control. Trop Med Parasitol 1989; 40:361-6.
12. Dadzie KY, Awadzi K, Bird AC, Schulz-Key H. Ophthalmological results from a placebo controlled comparative 3-dose ivermectin study in the treatment of onchocerciasis. Trop Med Parasitol 1989; 40:355-60.
13. Semba RD, Murphy RP, Newland HS, Awadzi K, Greene BM, Taylor HR. Longitudinal study of lesions of the posterior segment in onchocerciasis. Ophthalmology 1990; 97:1334-41.
14. Whitworth JAG, Gilbert CE, Mabey DM, Maude GH, Morgan D, Taylor DW. Effects of repeated doses of ivermectin on ocular onchocerciasis: community-based trial in Sierra Leone. Lancet 1991; 338:1100-3.
15. Newland HS, White AT, Greene BM, D'Anna SA, Keyvan-Larijani E, Aziz MA, Williams PN, Taylor HR. Effect of single-dose invermectin therapy on human Onchocerca volvulus infection with onchocercal ocular involvement. Br J Ophthalmol 1988; 72:561-9.
16. Abiose A, Jones BR, Cousens SN, Murdoch I, Cassels-Brown A, Babalola OE, Alexander NDE, Nuhu I, Evans J, Ibrahim UF, Mahmood AO. Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis. Lancet 1993; 341:130-4.
17. Mabey D, Whitworth JA, Eckstein M, Gilbert C, Maude G, Downham M. The effects of multiple doses of ivermectin on ocular onchocerciasis. A six-year follow-up. Ophthalmology 1996; 103:1001-8.
18. Prodhon J, Boussinesq M, Fobi G, Prud'hon JM, Enyong P, Lafleur C, Quillévéré D. Lutte contre l'onchocercose par ivermectine: résultats d'une campagne de masse au Nord-Cameroun. Bull WHO 1991; 69:443-50.
19. Boussinesq M, Prod'hon J, Chippaux JP. Onchocerca volvulus: striking decrease in transmission in the Vina valley (Cameroon) after eight annual large scale ivermectin treatments. Trans R Soc Trop Med Hyg 1997; 91:82-6.
20. Anderson J, Fuglsang H, Hamilton PJS, Marshall TF de C. Studies on onchocerciasis in the United Cameroon Republic. II. Comparison of onchocerciasis in rain-forest and Sudan-savanna. Trans R Soc Trop Med Hyg 1974; 68:209-22.
21. Moreau JP, Prost A, Prod'hon J. Essai de normalisation de la méthodologie des enquêtes clinico-parasitologiques sur l'onchocercose en Afrique de l'Ouest. Méd Trop 1978; 38:43-51.
22. Remme J, Ba O, Dadzie KY, Karam M. A force-of-infection model for onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta River basin area. Bull WHO 1986; 64:667-81.
23. Rolland A. Résultats de deux examens oculaires pratiqués à 6 ans d'intervalle dans deux villages onchocerquiens de Haute-Volta. Bull WHO 1974; 51:257-61.
24. Rolland A, Thylefors B, Pairault C. Evolution sur neuf ans de l'onchocercose oculaire dans une communauté villageoise d'Afrique occidentale. Bull WHO 1978; 56:805-10.
25. Marshall TF de C, Anderson J, Fuglsang H. The incidence of eye lesions and visual impairment in onchocerciasis in relationship to the intensity of infection. Trans R Soc Trop Med Hyg 1986; 80:426-34.
26. Evans LS. Defining mean visual acuity. Am J Ophthalmol 1992; 113:217-8.
27. Murdoch ME, Hay RJ, Mackenzie CD, Williams JF, Ghalib HW, Cousens S, Abiose A, Jones BR. A clinical classification and grading system of the cutaneous changes in onchocerciasis. Brit J Dermatol 1993; 129:260-9.
28. Pearlman E. Experimental onchocercal keratitis. Parasitol Today 1996; 12:261-7.
29. Anderson J, Fuglsang H, Marshall TF de C. Studies on onchocerciasis in the United Cameroon Republic. III. A four year follow-up of 6 rain-forest and 6 Sudan-savanna villages. Trans R Soc Trop Med Hyg 1976; 70:362-73.
30. Anderson J, Fuglsang H, Marshall TF de C. Studies on onchocerciasis in the United Cameroon Republic. IV. The incidence of ocular lesions. Trans R Soc Trop Med Hyg 1978; 72:513-5.
31. Boussinesq M, Lafleur C, Audugé A, Fobi G, Ngosso A, Banos MT, Ernould JC, Prod'hon J, Chippaux JP. Effect of ivermectin on ocular onchocerciasis: Analysis of serial fundus photographs in Cameroon. Am J Trop Med Hyg 1994; 51 (suppl.):188-9.
32. Cooper PJ, Guderian RH, Proano R, Taylor DW. The pathogenesis of chorioretinal disease in onchocerciasis. Parasitol Today 1997; 13:94-8.
33. World Health Organization. The Effect of Repeated Ivermectin Treatment on Ocular Onchocerciasis. Report of an informal consultation. Document TDR/TDE/ONCHO/93.3. Geneva: WHO, 1993.
34. Cousens SN, Cassels-Brown A, Murdoch I, Babalola OE, Jatau D, Alexander ND, Evans JE, Danboyi P, Abiose A, Jones BR. Impact of annual dosing with ivermectin on progression of onchocercal visual field loss. Bull WHO 1997; 75:229-36.